A carregar...
SRPX2 boosts pancreatic cancer chemoresistance by activating PI3K/AKT axis
BACKGROUND AND AIM: This investigation was aimed at disclosing whether SRPX2 affected pancreatic cancer (PC) chemoresistance by regulating PI3K/Akt/mTOR signaling. METHODS: Totally 243 PC patients were recruited, and they were incorporated into partial remission (PR) group, stable disease (SD) group...
Na minha lista:
| Publicado no: | Open Med (Wars) |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
De Gruyter
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7718643/ https://ncbi.nlm.nih.gov/pubmed/33336063 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/med-2020-0157 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|